Search

Your search keyword '"Jelakovic, Bojan"' showing total 402 results

Search Constraints

Start Over You searched for: Author "Jelakovic, Bojan" Remove constraint Author: "Jelakovic, Bojan"
402 results on '"Jelakovic, Bojan"'

Search Results

1. General and abdominal adiposity and hypertension in eight world regions: a pooled analysis of 837 population-based studies with 7·5 million participants

2. Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults

3. Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

4. Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

7. Exploring Acute Pancreatitis in Kidney Transplant Recipients: A Multicentre Retrospective Cohort Analysis of Incidence, Causes, and Clinical Outcomes

13. MAY MEASUREMENT MONTH 2023 IN CROATIA, CLOSE TO GUINNESS RECORD

14. PREVALENCE, AWARENESS, TREATMENT AND CONTROL OF DYSLIPIDEMIA (LDL-CHOLESTEROL > 3.0 MMOL/L) IN CROATIA – EHUH 2 STUDY PRELIMINARY REPORT

18. MISSION 70/26 HAS SUCCESSFULLY STARTED IN CROATIA. DO YOU KNOW YOUR NUMBERS?

22. HIGH PREVALENCE OF METABOLIC SYNDROME AND HIGH INCIDENCE OF NEW ONSET HYPERTENSION IN RURAL POPULATION WITH NORMAL BLOOD PRESSURE RISE THE QUESTION WHETHER NORMAL IS REALLY NORMAL

26. HOME BLOOD PRESSURE MONITORING SHOULD BE IMPROVED IN CROATIA

31. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants

32. Immunomodulatory Effect of COVID-19 on HLA-Antibody Profile in Renal Transplant Recipients.

33. Renal Mechanisms and Heart Failure

34. Early Cardiovascular Dysfunction in Prehypertension

35. Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

36. The Hypertension Excellence Centre programme of the European Society of Hypertension – current status, activities and reshaping for the future

39. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults

44. Serological Response to SARS-CoV-2 Vaccine in Hemodialyzed Patients and the Association with Later COVID-19 Positivity

46. Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Catalog

Books, media, physical & digital resources